glp-1 fda approved for weight loss Wegovy Pill Wins Approval as First Oral Treatment Obesity and Is GLP-1 Safe for Weight
Description
& Llorca, J

, , ()
Forbes: Trump Administration Says it Wants More OTC Meds But So Far No Action What do you think

This manuscript provides a comprehensive summary of the clinical pharmacology of GLP-1RAs and GLP-1/GIP dual receptor agonists, with particular emphasis on tirzepatide.19 The objective was to comprehensively review their pharmacological properties and clinical applications, thereby supporting precision medicine and rational pharmacotherapy within the authors clinical setting

Relevant for clinical practice, our findings show that treatment with semaglutide lowered the risk of MACE compared to sitagliptin, while tirzepatide showed at least comparable benefit to dulaglutide, an older GLP-1 receptor agonist with established cardiovascular efficacy

Its helpful to understand what youre seeing
